H.R.220 - National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. Smith, Christopher H. [R-NJ-4] (Introduced 01/03/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 01/25/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.220 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (01/03/2019)
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019
This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group.
The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must:
- support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders;
- establish a surveillance system to track the prevalence of such diseases and disorders in humans;
- establish a surveillance system to track the prevalence of disease-carrying ticks;
- conduct educational campaigns; and
- hold a series of research symposiums.